日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Follow-Up Bias in Tumor Dynamic Modeling: A Comparison of Classical and Neural-ODE Approaches

肿瘤动态建模中的随访偏差:经典方法与神经常微分方程方法的比较

Turner, David C; Laurie, Mark; Li, Shuhui; Ngo, Huy X; Li, Chunze; Jin, Jin Y; Lu, James; Brooks, Logan

Clinical Pharmacology of Cytokine Release Syndrome with T-Cell-Engaging Bispecific Antibodies: Current Insights and Drug Development Strategies

利用T细胞结合双特异性抗体治疗细胞因子释放综合征的临床药理学:最新进展和药物研发策略

Radtke, Kendra K; Bender, Brendan C; Li, Zao; Turner, David C; Roy, Sumedha; Belousov, Anton; Li, Chi-Chung

A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma

一种提高莫苏妥珠单抗治疗复发或难治性滤泡性淋巴瘤获益风险比的新型递增剂量方案

Li, Chi-Chung; Bender, Brendan; Wilkins, Justin; Li, Feifei; Turner, David C; Wang, Bei; Deng, Rong; Vadhavkar, Shweta; Li, Zao; Kwan, Antonia; Huang, Huang; Peng, Kun; Penuel, Elicia; Huw, Ling-Yuh; Chanu, Pascal; Li, Chunze; Yin, Shen; Wei, Michael C

Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHL

托珠单抗用于治疗复发/难治性B细胞非霍奇金淋巴瘤患者中T细胞结合双特异性抗体相关细胞因子释放综合征的剂量

Jamois, Candice; Turner, David C; Gibiansky, Leonid; Li, Feifei; Menuet, Jean-Francois; Pereira, Leonardo Roque; Lundberg, Linda; Guerini, Elena; Carlile, David J; Relf, James; Wei, Michael C; Kwan, Antonia; Frey, Nicolas; Grange, Susan

Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma.

莫苏妥珠单抗在中国复发或难治性滤泡性淋巴瘤患者中的药代动力学和药效学的种族敏感性评估

Li Junyi, Liao Michael Z, Wilkins Justin, Penuel Elicia, Wang Bei, Vadhavkar Shweta, Peng Kun, Cao Junning, Li Zhiming, Zhang Ye, Li Wenjin, Li Donghang, Zhou Mingzhu, Wei Michael C, Kwan Antonia, Zhao Rong, Li Chunze, Li Chi-Chung, Turner David C

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma

莫苏妥珠单抗在复发/难治性B细胞非霍奇金淋巴瘤中的群体药代动力学和CD20结合动力学

Bender, Brendan; Li, Chi-Chung; Marchand, Mathilde; Turner, David C; Li, Feifei; Vadhavkar, Shweta; Wang, Bei; Deng, Rong; Lu, James; Jin, Jin; Li, Chunze; Yin, Shen; Wei, Michael; Chanu, Pascal

Model-based meta-analysis of non-small cell lung cancer with standard of care PD-1 inhibitors and chemotherapy for early development decision making

基于模型的非小细胞肺癌标准治疗方案(PD-1抑制剂联合化疗)荟萃分析,用于早期研发决策

Turner, David C; Wada, Russ; Zhou, Helen; Wang, Xiaowei; de Greef, Rik; Valiathan, Chandni; Zhang, Lindsey; Zhang, Nancy; Kuchimanchi, Mita; Chen, Tai-Tsang; Ballas, Marc; Visser, Sandra A G

Pharmacokinetics of biologics in gastric cancer

胃癌生物制剂的药代动力学

Li, Junyi; Turner, David C; Li, Feifei; Chen, Xi; Liao, Michael Z; Li, Chunze

Immunogenicity of pembrolizumab in patients with advanced tumors

帕博利珠单抗在晚期肿瘤患者中的免疫原性

van Vugt, Marianne J H; Stone, Julie A; De Greef, Rik H J M M; Snyder, Ellen S; Lipka, Leslie; Turner, David C; Chain, Anne; Lala, Mallika; Li, Mengyao; Robey, Seth H; Kondic, Anna G; De Alwis, Dinesh; Mayawala, Kapil; Jain, Lokesh; Freshwater, Tomoko

Inducing protein aggregation by extensional flow

通过拉伸流动诱导蛋白质聚集

John Dobson, Amit Kumar, Leon F Willis, Roman Tuma, Daniel R Higazi, Richard Turner, David C Lowe, Alison E Ashcroft, Sheena E Radford, Nikil Kapur, David J Brockwell